Galecto discloses SVB exposure under $1.5M; no material impact expected

Damora Therapeutics, Inc.

FDIC took control of Silicon Valley Bank on March 10, 2023 due to liquidity concerns.
Galecto's cash deposits at SVB total less than $1.5 million, excluding FDIC-insured amounts.
Company does not anticipate any material effect on its operating plan or cash runway.

item 7.01

Damora Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-007228

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.